Cargando…

The Anti-Pseudomonal Peptide D-BMAP18 Is Active in Cystic Fibrosis Sputum and Displays Anti-Inflammatory In Vitro Activity

Most Cystic Fibrosis (CF) patients succumb to airway inflammation and pulmonary infections due to Pseudomonas aeruginosa. D-BMAP18, a membrane-permeabilizing antimicrobial peptide composed of D-amino acids, was evaluated as a possible antibacterial aimed to address this issue. The antipseudomonal ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Degasperi, Margherita, Agostinis, Chiara, Mardirossian, Mario, Maschio, Massimo, Taddio, Andrea, Bulla, Roberta, Scocchi, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565916/ https://www.ncbi.nlm.nih.gov/pubmed/32932703 http://dx.doi.org/10.3390/microorganisms8091407

Ejemplares similares

D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection
por: Mardirossian, Mario, et al.
Publicado: (2017)

Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections
por: Degasperi, Margherita, et al.
Publicado: (2022)

Effect of iron chelation on anti-pseudomonal activity of doxycycline
por: Faure, ME, et al.
Publicado: (2021)

De-Escalating Anti-Pseudomonal β-Lactams
por: Catteeuw, J, et al.
Publicado: (2015)

Safety of intravenous tobramycin in combination with a variety of anti-pseudomonal antibiotics in children with cystic fibrosis
por: Deschamp, Ashley R, et al.
Publicado: (2017)

Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of resistance to other anti‐pseudomonal β‐lactams?
por: Lodise, Thomas P., et al.
Publicado: (2021)

Efficacy of anti-pseudomonal antibiotics: Need to reconsider the empirical use of cefepime
por: Kotwal, A., et al.
Publicado: (2014)

Killing of Trypanosomatid Parasites by a Modified Bovine Host Defense Peptide, BMAP-18
por: Haines, Lee R., et al.
Publicado: (2009)

Multifunctional Properties of BMAP-18 and Its Aliphatic Analog against Drug-Resistant Bacteria
por: Jahan, Ishrat, et al.
Publicado: (2023)

Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm
por: Lutz, Larissa, et al.
Publicado: (2012)

Empiric Usage of “Anti-Pseudomonal” Agents for Hospital-Acquired Urinary Tract Infections
por: Rahat, Ori, et al.
Publicado: (2022)

Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens
por: Sola, Riccardo, et al.
Publicado: (2020)

Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia
por: Pompilio, Arianna, et al.
Publicado: (2012)

Risk of acute kidney injury associated with anti-pseudomonal and anti-MRSA antibiotic strategies in critically ill patients
por: Côté, Jean-Maxime, et al.
Publicado: (2022)

The In Vitro Anti-Pseudomonal Activity of Cu(2+), Strawberry Furanone, Gentamicin, and Lytic Phages Alone and in Combination: Pros and Cons
por: Dorotkiewicz-Jach, Agata, et al.
Publicado: (2021)

Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients
por: Ormerod, Kate L., et al.
Publicado: (2015)

Effectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study
por: Shiroshita, Akihiro, et al.
Publicado: (2021)

1883. Acute Kidney Injury in Patients With Pneumonia on Concomitant Anti-Methicillin-Resistant Staphylococcus aureus and Anti-Pseudomonal β-Lactam Therapy
por: Raux, Brian R, et al.
Publicado: (2018)

Evaluation of a Computerized Decision Support Intervention to Decrease Use of Anti-Pseudomonal Carbapenems in Penicillin Allergic Patients
por: Caplinger, Christina, et al.
Publicado: (2016)

Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia
por: Tran, Nikki N, et al.
Publicado: (2023)

Zinc Oxide Exerts Anti-Inflammatory Properties on Human Placental Cells
por: Balduit, Andrea, et al.
Publicado: (2020)

RelB activation in anti-inflammatory decidual endothelial cells: a master plan to avoid pregnancy failure?
por: Masat, Elisa, et al.
Publicado: (2015)

The Antibacterial and Anti-biofilm Traits of the Novel BMAP-27-Melittin Conjugated Peptide Nanoparticle Against Streptococcus mutans: Clinical Isolates from Oral Cavity
por: Pourahmadi, Mohammad, et al.
Publicado: (2022)

Design and characterization of a new hybrid peptide from LL-37 and BMAP-27
por: Al Tall, Yara, et al.
Publicado: (2019)

Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules
por: Schneider-Futschik, Elena K., et al.
Publicado: (2018)

Correction to: Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia
Publicado: (2023)

Pseudomonal Diabetic Foot Infections: Vive la Différence?
por: Uçkay, Ilker, et al.
Publicado: (2022)

239. Outcomes Associated with Empiric Aztreonam Use Compared to Anti-Pseudomonal β-lactams in Patients with Sepsis: An Opportunity for Allergy Stewardship
por: Jaffa, Rupal K, et al.
Publicado: (2020)

Association Between Empirical Anti-Pseudomonal Antibiotics for Recurrent Lower Respiratory Tract Infections and Mortality: A Retrospective Cohort Study
por: Shiroshita, Akihiro, et al.
Publicado: (2022)

Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach
por: Abrami, Michela, et al.
Publicado: (2022)

Effect of Glycyrrhizin on Pseudomonal Skin Infections in Human-Mouse Chimeras
por: Yoshida, Shohei, et al.
Publicado: (2014)

Novel synthesis of 1,2-diaza-1,3-dienes with potential biological activity from cinnamic acids and diazonium salts of anilines
por: Vida, Veronica, et al.
Publicado: (2022)

Piperacillin-Tazobactam Versus Anti-Pseudomonal Cephalosporins and Renal and Neurologic Outcomes in Critically Ill Adults: A Secondary Analysis of the SMART Trial
por: Qian, Edward T., et al.
Publicado: (2023)

Anti-Spike Antibodies Present in the Milk of SARS-CoV-2 Vaccinated Mothers Are Complement-Activating
por: Agostinis, Chiara, et al.
Publicado: (2023)

Neutrophil count in sputum is associated with increased sputum glucose and sputum L-lactate in cystic fibrosis
por: Nielsen, Bibi Uhre, et al.
Publicado: (2020)

Methylprednisolone/tocilizumab: Fungal sepsis and pseudomonal pneumonia: 2 case reports
Publicado: (2021)

Rapid Identification of Gram-Negative Bacteremia and Impact on Anti-Pseudomonal Antibiotic Consumption in Combination with Antibiotic Stewardship at a Community-Based Hospital System
por: Box, Maggie, et al.
Publicado: (2017)

Azithromycin and the microbiota of cystic fibrosis sputum
por: Acosta, Nicole, et al.
Publicado: (2021)

Effect of BMAP-28 Antimicrobial Peptides on Leishmania major Promastigote and Amastigote Growth: Role of Leishmanolysin in Parasite Survival
por: Lynn, Miriam A., et al.
Publicado: (2011)

Inhibitory effect of BMAP-28 on Leptospiral Lipopolysaccharide-Induced TLR2-Dependent Immune Response in Bovine Cells
por: GUO, Yijie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mqj9bjkvmkju1ojhkcdt9rc03q